Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation (AHSCT) in systemic sclerosis patients?

stem cells transplantation

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 03 February 2016 - 10:17 AM

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation (AHSCT) in systemic sclerosis patients?

 

We demonstrate that CD34+ does not add benefit to the outcome of SSc patient treated with AHSCT and these findings should be further confirmed by prospective randomized trials. PubMed, Bone Marrow Transplant, 12/07/2015. (Also see Stem Cell (Bone Marrow) Transplantation)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)






Also tagged with one or more of these keywords: stem cells, transplantation